featured
Dupilumab Therapy and the Risk of Developing Cutaneous T-Cell Lymphoma in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study
J Am Acad Dermatol 2024 Apr 06;[EPub Ahead of Print], I Hasan, L Parsons, S Duran, Z ZinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.